{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:48:37Z","timestamp":1789886917505,"version":"4.0.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.rdc.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T18:23:06Z","timestamp":1528827786000},"page":"475-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases"],"prefix":"10.1016","volume":"44","author":[{"given":"Rachel H.","family":"Mackey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis H.","family":"Kuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rdc.2018.03.006_bib1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.semarthrit.2012.01.005","article-title":"Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a Medicare analysis","volume":"42","author":"Bartels","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib3","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3915","article-title":"Monitoring diabetes in patients with and without rheumatoid arthritis: a Medicare study","volume":"14","author":"Bartels","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/art.21560","article-title":"Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis","volume":"54","author":"Nicola","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.20855","article-title":"The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"13","key":"10.1016\/j.rdc.2018.03.006_bib6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/2012.jama.11741","article-title":"Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization","volume":"308","author":"Holmqvist","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.33322","article-title":"Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?","volume":"64","author":"Bacani","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.acvd.2010.03.007","article-title":"High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis","volume":"103","author":"Meune","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.rdc.2018.03.006_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","article-title":"Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies","volume":"48","author":"Meune","year":"2009","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2018.03.006_bib10","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avina-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2018.03.006_bib12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1002\/art.23798","article-title":"The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population","volume":"58","author":"Davis","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2018.03.006_bib13","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.39198","article-title":"Rheumatoid arthritis, anti-cyclic citrullinated peptide positivity, and cardiovascular disease risk in the Women's Health Initiative","volume":"67","author":"Mackey","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","article-title":"Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis","volume":"78","author":"Boyer","year":"2011","journal-title":"Jointt Bone Spine"},{"issue":"11","key":"10.1016\/j.rdc.2018.03.006_bib15","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/art.20636","article-title":"Cardiovascular risk factors in women with and without rheumatoid arthritis","volume":"50","author":"Solomon","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.rdc.2018.03.006_bib16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/art.23650","article-title":"High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study","volume":"58","author":"Kremers","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semarthrit.2011.07.004","article-title":"Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis","volume":"41","author":"Chung","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2018.03.006_bib18","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1002\/acr.22091","article-title":"Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population","volume":"65","author":"Liao","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.rdc.2018.03.006_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.rdc.2018.03.006_bib20","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/ard.2009.122374","article-title":"Total cholesterol and LDL levels decrease before rheumatoid arthritis","volume":"69","author":"Myasoedova","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2018.03.006_bib21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","article-title":"Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis","volume":"110","author":"Crowson","year":"2012","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.38944","article-title":"The ability of the 2013 American College of Cardiology\/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores","volume":"67","author":"Kawai","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream\u00a0to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib25","article-title":"Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients","volume":"5","author":"Sharma","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.rdc.2018.03.006_bib26","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","article-title":"Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease","volume":"108","author":"Micha","year":"2011","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib27","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/acr.20371","article-title":"Systematic review and meta-analysis: anti-tumor necrosis factor alpha therapy and cardiovascular events in rheumatoid arthritis","volume":"63","author":"Barnabe","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.rdc.2018.03.006_bib28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MOL.0000000000000256","article-title":"High-density lipoprotein function in rheumatoid arthritis","volume":"27","author":"Ormseth","year":"2016","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"10.1016\/j.rdc.2018.03.006_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2018.03.006_bib31","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/art.39165","article-title":"Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients","volume":"67","author":"Liao","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","article-title":"Clinical implications of discordance between low-density lipoprotein cholesterol and particle number","volume":"5","author":"Otvos","year":"2011","journal-title":"J\u00a0Clin Lipidol"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.atherosclerosis.2012.08.039","article-title":"Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study","volume":"225","author":"Sniderman","year":"2012","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.rdc.2018.03.006_bib34","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/2047487315569411","article-title":"Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C","volume":"22","author":"Pencina","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib35","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1373\/clinchem.2016.264515","article-title":"Discordance between circulating atherogenic cholesterol mass and lipoprotein particle concentration in relation to future coronary events in women","volume":"63","author":"Lawler","year":"2017","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.rdc.2018.03.006_bib36","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.rdc.2018.03.006_bib37","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/rheumatology\/ker204","article-title":"Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset\u2013a prospective cohort study","volume":"50","author":"Ajeganova","year":"2011","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.rdc.2018.03.006_bib38","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/acr.21646","article-title":"Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis","volume":"64","author":"Knowlton","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.38920","article-title":"An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy","volume":"67","author":"Rao","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/03009742.2013.877158","article-title":"The ApoB\/ApoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis","volume":"43","author":"Ohman","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2018.03.006_bib41","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5","article-title":"Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile","volume":"44","author":"Hurt-Camejo","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib42","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2009.07.015","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis","volume":"207","author":"Rizzo","year":"2009","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.rdc.2018.03.006_bib43","first-page":"2311","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis\u2013the Third National Health and Nutrition Examination Survey","volume":"32","author":"Choi","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2018.03.006_bib44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.38974","article-title":"Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib","volume":"67","author":"Charles-Schoeman","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2018.03.006_bib45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1373\/clinchem.2008.118356","article-title":"Apolipoprotein B and cardiovascular disease risk: position statement from the AACC lipoproteins and vascular diseases division working group on best practices","volume":"55","author":"Contois","year":"2009","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.rdc.2018.03.006_bib46","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/dc08-1681","article-title":"Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study","volume":"32","author":"Rosenson","year":"2009","journal-title":"Diabetes care"},{"issue":"21","key":"10.1016\/j.rdc.2018.03.006_bib47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"6 Suppl","key":"10.1016\/j.rdc.2018.03.006_bib48","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"J\u00a0Clin Lipidol"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.rdc.2018.03.006_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/ard.2006.051672","article-title":"Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis","volume":"66","author":"van Halm","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2018.03.006_bib51","doi-asserted-by":"crossref","first-page":"R116","DOI":"10.1186\/ar2323","article-title":"Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation","volume":"9","author":"Hannawi","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.rdc.2018.03.006_bib52","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1160\/TH14-11-0921","article-title":"Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies","volume":"113","author":"Ambrosino","year":"2015","journal-title":"Thromb Haemost"},{"issue":"11","key":"10.1016\/j.rdc.2018.03.006_bib53","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1002\/art.30542","article-title":"Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis","volume":"63","author":"Giles","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2018.03.006_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2796.2009.02123.x","article-title":"Prevalence and extent of calcification over aorta, coronary and carotid arteries in patients with rheumatoid arthritis","volume":"266","author":"Wang","year":"2009","journal-title":"J\u00a0Intern Med"},{"issue":"10","key":"10.1016\/j.rdc.2018.03.006_bib55","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2018.03.006_bib56","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.3899\/jrheum.160053","article-title":"Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis","volume":"43","author":"Ikdahl","year":"2016","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2018.03.006_bib57","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.21349","article-title":"How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?","volume":"52","author":"Crowson","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2018.03.006_bib58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/rheumatology\/kes349","article-title":"Myocardial ischaemia without obstructive coronary artery disease in rheumatoid arthritis: hypothesis generating insights from a cross-sectional study","volume":"52","author":"Toutouzas","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2018.03.006_bib59","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3899\/jrheum.130365","article-title":"Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study","volume":"40","author":"Ajeganova","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rdc.2018.03.006_bib60","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20878","article-title":"Cardiovascular death in rheumatoid arthritis: a population-based study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2018.03.006_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ard.2006.053710","article-title":"Raised erythrocyte sedimentation rate signals heart failure in patients with rheumatoid arthritis","volume":"66","author":"Maradit-Kremers","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A\u00a0novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib63","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acr.21861","article-title":"Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review","volume":"65","author":"Aslam","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"7","key":"10.1016\/j.rdc.2018.03.006_bib64","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/art.37949","article-title":"Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a populationbased cross-sectional study","volume":"65","author":"Myasoedova","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib65","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.27349","article-title":"Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging","volume":"62","author":"Giles","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2018.03.006_bib66","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping","volume":"8","author":"Ntusi","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.rdc.2018.03.006_bib67","doi-asserted-by":"crossref","first-page":"R171","DOI":"10.1186\/ar3131","article-title":"Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study","volume":"12","author":"Kobayashi","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib68","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.acra.2017.10.017","article-title":"One-year follow-up study detects myocardial changes with cardiovascular magnetic resonance tagging in active rheumatoid arthritis","volume":"25","author":"Lehmonen","year":"2018","journal-title":"Acad Radiol"},{"issue":"11","key":"10.1016\/j.rdc.2018.03.006_bib69","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/1756-185X.12632","article-title":"Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging","volume":"19","author":"Kobayashi","year":"2016","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.rdc.2018.03.006_bib70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/annrheumdis-2014-206411","article-title":"The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease","volume":"75","author":"Myasoedova","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2018.03.006_bib71","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/acr.23138","article-title":"Magnetic resonance imaging-detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-terminal pro-brain natriuretic peptide levels","volume":"69","author":"Kobayashi","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"5","key":"10.1016\/j.rdc.2018.03.006_bib72","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.semarthrit.2010.06.006","article-title":"Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis","volume":"40","author":"van Sijl","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2018.03.006_bib73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3899\/jrheum.120621","article-title":"Carotid plaque characteristics and disease activity in rheumatoid arthritis","volume":"40","author":"Semb","year":"2013","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2018.03.006_bib74","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3899\/jrheum.121302","article-title":"Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study","volume":"40","author":"Akkara Veetil","year":"2013","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2018.03.006_bib75","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/art.39195","article-title":"Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2018.03.006_bib76","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/acr.22752","article-title":"Rheumatoid arthritis and mortality among women during 36\u00a0years of prospective follow-up: Results from the Nurses\u2019 Health Study","volume":"68","author":"Sparks","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib77","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","article-title":"Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis","volume":"66","author":"Reynisdottir","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2018.03.006_bib78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2010.05.007","article-title":"Subclinical peripheral arterial disease in rheumatoid arthritis","volume":"212","author":"Stamatelopoulos","year":"2010","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.rdc.2018.03.006_bib79","first-page":"835","volume":"26","author":"Di Minno","year":"2015","journal-title":"Clinical assessment of endothelial function in patients with rheumatoid arthritis: a meta-analysis of literature studies.Eur J Intern Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X18300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X18300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:17:04Z","timestamp":1760181424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X18300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0889857X18300310"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2018.03.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}